POCI — Precision Optics Corporation, Inc.

Precision Optics (POCI) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: Q1 revenue reached $6.7 million, a 46% increase year-over-year from $4.2 million and up from $6.2 million sequentially.
• Production Revenue: Approximately $6 million, compared to $2.6 million in the prior year and $5.1 million sequentially.
• Engineering Revenue: $656,000, down from $1.6 million year-over-year and $1.1 million sequentially.
• Gross Margin: 14.4%, an increase from 12.9% sequentially but down from 26.6% year-over-year.
• Net Loss: $1.6 million, compared to a loss of $1.3 million in the previous year.
• Adjusted EBITDA: Negative $1.2 million, slightly worse than the negative $1.0 million in the prior year.
• Cash Position: $1.4 million in cash and $1.7 million in debt.

2. Strategic Updates and Business Highlights

• Production Programs: Continued strong performance in key manufacturing programs, particularly in aerospace (record revenue of $2.5 million net of tariffs) and surgical robotics (cystoscope program revenue of $1.5 million).
• New Development Agreements: Secured two new large development contracts in augmented reality for defense and a high-resolution borescope for jet engine inspection, indicating a strategic pivot towards aerospace and defense markets alongside medical devices.
• Infrastructure Improvements: Ongoing updates to production facilities to enhance capacity and efficiency, with expectations of increased throughput by 50% in the aerospace program.
• Sales and Marketing Enhancements: New leadership and strategies in sales and marketing are beginning to yield results, with an uptick in product development leads.

3. Forward Guidance and Outlook

• Revenue Expectations: The company anticipates fiscal year 2026 revenue to exceed $25 million, supported by ongoing growth in production and development programs.
• Adjusted EBITDA: Expected to reach approximately $0.5 million for the year despite the current quarter's loss.
• Margin Improvements: Anticipated improvements in gross margins as production efficiencies are realized and new programs transition from development to production.

4. Challenges and Points of Concern

• Gross Margin Pressure: Current gross margins remain low due to production ramp-up challenges and under-absorption of engineering resources.
• Delayed Orders: A significant reorder for a legacy defense program has been delayed, which could impact future revenue.
• Product Development Revenue Decline: Engineering revenue was notably low in Q1, attributed to the transition of programs from development to production.
• Operational Growing Pains: The company is facing challenges associated with scaling operations, which have required significant changes to infrastructure and processes.

5. Notable Q&A Insights

• Market Focus: The company is not pivoting away from medical devices but is increasing its presence in the defense and aerospace sectors, which can offer faster development timelines.
• Capacity Utilization: Future capacity expansions are expected to support significant revenue growth, potentially doubling current production capabilities.
• Automation Potential: Opportunities for automation exist but are contingent on achieving higher production volumes in the coming years.
• Customer Relationships: The borescope project is specifically for a major jet engine manufacturer, indicating a strong partnership that could lead to substantial future revenue.

Overall, Precision Optics is experiencing strong revenue growth driven by key production programs, though it faces challenges with margins and operational scaling. The outlook remains positive with significant growth expected in both revenue and profitability as the company continues to adapt and expand its capabilities.